A retrospective evaluation of a multidisciplinary management strategy implemented to optimize outpatient care, hospitalization rates and clinical outcomes in a single-centre cohort of COVID-19-positive pregnant women In Australia during the Omicron BA.1 surge (ORIGINAL ARTICLE)
Dublin Core
Title
A retrospective evaluation of a multidisciplinary management strategy implemented to optimize outpatient care, hospitalization rates and clinical outcomes in a single-centre cohort of COVID-19-positive pregnant women In Australia during the Omicron BA.1 surge (ORIGINAL ARTICLE)
Subject
COVID-19, pregnant, outpatient, budesonide, sotrovimab, hospitalization
Description
Background: During the Omicron BA.1 surge between 12 January and 18 February 2022, 189 COVID-19-positive pregnant women were managed by the Peninsula Health Positive Pathways program, in the Mornington Peninsula, Victoria, Australia. A multidisciplinary specialist team
was rapidly assembled to work in conjunction with the Pathways COVID-19 physicians and monitoring team, to optimize patient care.
Objective: The aim is to describe the processes utilized to care for the pregnancy cohort from the time of enrolment to the COVID Monitor until
recovery including outpatient monitoring, treatment strategies, hospital review criteria, and clinical outcomes including rate of hospitalization,
oxygen requirements, and maternal and foetal outcomes during the study period.
Method: Outpatients were monitored daily by the Pathways program, while COVID-19 physicians and obstetricians conducted early telehealth
review of patients after diagnosis. Members of the multidisciplinary team met on a virtual platform twice daily, and institution-specific treatment
guidelines and hospital review criteria were established. Enoxaparin prophylaxis was delivered to the homes of selected patients, and inhaled
budesonide was utilized for patients who did not require oxygen, who were immunocompromised, and who had significant respiratory symptoms
or risk factors for deterioration. Sotrovimab was offered to women as per the existing Australian National COVID-19 Clinical Evidence Taskforce
eligibility criteria. A service evaluation was undertaken adopting a retrospective cohort approach.
Results: There was minimal maternal morbidity and no mortality with 24/189 (12.7%) women requiring hospitalization, 18/189 (9.5%) requiring
same-day emergency department presentations only, and 4/189 (2.1%) requiring oxygen, with no requirement for non-invasive ventilation or
intensive care unit admission. Sixteen patients delivered live newborns during the study period, and there were two pregnancy losses at 7 and
19 weeks gestation, respectively, in patients with prior pregnancy complications.
Conclusion: A multidisciplinary approach involving virtual communication twice daily between treating specialist physicians may be a broadly
applicable model to optimize care of pregnant women with COVID-19
was rapidly assembled to work in conjunction with the Pathways COVID-19 physicians and monitoring team, to optimize patient care.
Objective: The aim is to describe the processes utilized to care for the pregnancy cohort from the time of enrolment to the COVID Monitor until
recovery including outpatient monitoring, treatment strategies, hospital review criteria, and clinical outcomes including rate of hospitalization,
oxygen requirements, and maternal and foetal outcomes during the study period.
Method: Outpatients were monitored daily by the Pathways program, while COVID-19 physicians and obstetricians conducted early telehealth
review of patients after diagnosis. Members of the multidisciplinary team met on a virtual platform twice daily, and institution-specific treatment
guidelines and hospital review criteria were established. Enoxaparin prophylaxis was delivered to the homes of selected patients, and inhaled
budesonide was utilized for patients who did not require oxygen, who were immunocompromised, and who had significant respiratory symptoms
or risk factors for deterioration. Sotrovimab was offered to women as per the existing Australian National COVID-19 Clinical Evidence Taskforce
eligibility criteria. A service evaluation was undertaken adopting a retrospective cohort approach.
Results: There was minimal maternal morbidity and no mortality with 24/189 (12.7%) women requiring hospitalization, 18/189 (9.5%) requiring
same-day emergency department presentations only, and 4/189 (2.1%) requiring oxygen, with no requirement for non-invasive ventilation or
intensive care unit admission. Sixteen patients delivered live newborns during the study period, and there were two pregnancy losses at 7 and
19 weeks gestation, respectively, in patients with prior pregnancy complications.
Conclusion: A multidisciplinary approach involving virtual communication twice daily between treating specialist physicians may be a broadly
applicable model to optimize care of pregnant women with COVID-19
Creator
Emma Jane Bishop, Jolyon Ford, Pamela Rosengarten, Fergus McGee, Kelly Griffin, Travis Churchill, and Marjoree M. Sehu
Source
DOI:https://doi.org/10.1093/ijcoms/lyad008
Publisher
Oxford University Press
Date
5 June 2023
Contributor
Sri Wahyuni
Format
PDF
Language
English
Type
Text
Files
Collection
Citation
Emma Jane Bishop, Jolyon Ford, Pamela Rosengarten, Fergus McGee, Kelly Griffin, Travis Churchill, and Marjoree M. Sehu, “A retrospective evaluation of a multidisciplinary management strategy implemented to optimize outpatient care, hospitalization rates and clinical outcomes in a single-centre cohort of COVID-19-positive pregnant women In Australia during the Omicron BA.1 surge (ORIGINAL ARTICLE),” Repository Horizon University Indonesia, accessed February 21, 2026, https://repository.horizon.ac.id/items/show/11201.